Descriptions

The autoinhibited protein was predicted that may have potential autoinhibitory elements via cis-regPred.

Autoinhibitory domains (AIDs)

Target domain

Relief mechanism

Assay

cis-regPred

Accessory elements

No accessory elements

Autoinhibited structure

Activated structure

1 structures for Q8BGF7

Entry ID Method Resolution Chain Position Source
AF-Q8BGF7-F1 Predicted AlphaFoldDB

50 variants for Q8BGF7

Variant ID(s) Position Change Description Diseaes Association Provenance
rs3389137510 17 M>I No EVA
rs3389140038 23 P>L No EVA
rs3401560523 31 P>HSVANLDSGGHPGLGPG* No EVA
rs248914054 33 L>M No EVA
rs248544392 133 T>S No EVA
rs3389133095 137 L>F No EVA
rs36862080 161 V>L No EVA
rs3389122500 162 L>F No EVA
rs3389111019 205 T>S No EVA
rs3389135922 209 F>L No EVA
rs3389140011 246 G>S No EVA
rs3389144340 254 F>I No EVA
rs3389133262 274 M>I No EVA
rs3389139995 287 P>Q No EVA
rs3389145212 352 G>A No EVA
rs3389106286 426 V>M No EVA
rs3389127410 447 R>L No EVA
rs3401560519 451 R>S No EVA
rs3389131154 478 R>* No EVA
rs3400580804 547 H>L No EVA
rs3401679248 552 E>G No EVA
rs3389133064 685 P>R No EVA
rs248137135 706 E>D No EVA
rs3389073036 716 C>S No EVA
rs3389127425 728 I>F No EVA
rs3401875423 818 C>F No EVA
rs3402035690 821 A>S No EVA
rs29318900 822 D>E No EVA
rs3389127438 833 S>A No EVA
rs3401833632 838 A>* No EVA
rs230005407 844 L>H No EVA
rs3389145256 866 S>N No EVA
rs3389145233 874 G>C No EVA
rs3389139967 895 F>L No EVA
rs259288813 962 L>M No EVA
rs3389133269 968 P>S No EVA
rs3389133986 969 Q>* No EVA
rs3389140042 971 G>A No EVA
rs3389145214 971 G>R No EVA
rs3389144413 1072 I>F No EVA
rs3389133984 1096 K>M No EVA
rs233791537 1107 H>Q No EVA
rs3389146634 1107 H>Y No EVA
rs228385379 1135 S>R No EVA
rs3389133089 1149 Y>F No EVA
rs3389131158 1161 S>P No EVA
rs3389136005 1169 L>I No EVA
rs3389133063 1177 D>V No EVA
rs3389131155 1188 S>N No EVA
rs3389137549 1196 S>L No EVA

No associated diseases with Q8BGF7

No regional properties for Q8BGF7

Type Name Position InterPro Accession
No domain, repeats, and functional sites for Q8BGF7

Functions

Description
EC Number 3.1.13.4 Exoribonucleases producing 5'-phosphomonoesters
Subcellular Localization
  • Cytoplasm, P-body
  • Nucleus
  • Shuttles between nucleus and cytoplasm
PANTHER Family
PANTHER Subfamily
PANTHER Protein Class
PANTHER Pathway Category No pathway information available

4 GO annotations of cellular component

Name Definition
cytoplasm The contents of a cell excluding the plasma membrane and nucleus, but including other subcellular structures.
nucleus A membrane-bounded organelle of eukaryotic cells in which chromosomes are housed and replicated. In most cells, the nucleus contains all of the cell's chromosomes except the organellar chromosomes, and is the site of RNA synthesis and processing. In some species, or in specialized cell types, RNA metabolism or DNA replication may be absent.
P-body A focus in the cytoplasm where mRNAs may become inactivated by decapping or some other mechanism. Protein and RNA localized to these foci are involved in mRNA degradation, nonsense-mediated mRNA decay (NMD), translational repression, and RNA-mediated gene silencing.
PAN complex A complex that possesses poly(A)-specific ribonuclease activity; catalyzes the message-specific shortening of mRNA poly(A) tails. Contains at least two subunits, known as Pan2p and Pan3p in Saccharomyces.

4 GO annotations of molecular function

Name Definition
3'-5'-exoribonuclease activity Catalysis of the sequential cleavage of mononucleotides from a free 3' terminus of an RNA molecule.
metal ion binding Binding to a metal ion.
nucleic acid binding Binding to a nucleic acid.
poly(A)-specific ribonuclease activity Catalysis of the exonucleolytic cleavage of poly(A) to 5'-AMP.

4 GO annotations of biological process

Name Definition
mRNA processing Any process involved in the conversion of a primary mRNA transcript into one or more mature mRNA(s) prior to translation into polypeptide.
nuclear-transcribed mRNA catabolic process, exonucleolytic The chemical reactions and pathways resulting in the breakdown of the transcript body of a nuclear-transcribed mRNA that occurs when the ends are not protected by the 5'-cap or the 3'-poly(A) tail.
nuclear-transcribed mRNA poly(A) tail shortening Shortening of the poly(A) tail of a nuclear-transcribed mRNA from full length to an oligo(A) length.
positive regulation of cytoplasmic mRNA processing body assembly Any process that increases the rate, frequency, or extent of the aggregation, arrangement and bonding together of proteins and RNA molecules to form a cytoplasmic mRNA processing body.

1 homologous proteins in AiPD

UniProt AC Gene Name Protein Name Species Evidence Code
Q504Q3 PAN2 PAN2-PAN3 deadenylation complex catalytic subunit PAN2 Homo sapiens (Human) PR
10 20 30 40 50 60
MNFEGLDPGL AEFSPAMHST LDPVLDAHLN PSLLQNVELD PEGVALEALP VQESVHIMEG
70 80 90 100 110 120
VYSELHSVVA EVGVPVSVSH FDLHEEMLWV GSHGGHATSF FGPALERYSS FQVNGGDDIR
130 140 150 160 170 180
QIQSLENGIL FLTKNNLKYM ARGGLIIFDY LLDENEDMHS VLLTDNSTLL VGGLQNHVLE
190 200 210 220 230 240
IDLNTVQETQ KYAVETPGVT IMRQTNRFFF CGHTSGKVSL RDLRSFKVEH EFDAFSGSLS
250 260 270 280 290 300
DFDVHGNLLA ACGFSSRLTG LACDRFLKVY DLRMMRAITP LQVHVDPAFL RFIPTYTSRL
310 320 330 340 350 360
AIISQSGQCQ FCEPTGLANP ADIFHVNPVG PLLMTFDVSA SKQALAFGDS EGCVHLWTDS
370 380 390 400 410 420
PEPSFNPYSR ETEFALPCLV DSLPPLDWSQ DLLPLSLIPV PLTTDALLSD WPAANSAPAP
430 440 450 460 470 480
RRAPPVDAEI LRTMKKVGFI GYAPNPRTRL RNQIPYRLKE SDHEFDNFSQ VTESPTGREE
490 500 510 520 530 540
EPLHTVSKKY RKVTIKYSKL GLEDFDFKHY NKTLFAGLEP HIPNAYCNCM IQVLYFLEPV
550 560 570 580 590 600
RCLIQNHLCQ KEFCLACELG FLFHMLDLSR GDPCQGSNFL RAFRTIPEAS ALGLILADSD
610 620 630 640 650 660
EASGKGSLAR LIQRWNRFIL TQLHQDMQEL EVPQAYRGAG GSFCSSGDSI IGQLFSCEME
670 680 690 700 710 720
NCSLCRCGSE TVRASSTLLF TLSYPEDKTG KNYDFAQVLK RSICLEQNTQ AWCDNCEKYQ
730 740 750 760 770 780
PTIQTRNIRH LPDILVINCE VNSSKEADFW RLQAEVAFKI AVKKYGGEMK SKEFALADRK
790 800 810 820 830 840
ELRSPEGFLC SSIEELKNVW LPFSIRMKMT KNKGLDVCNW ADEHELSSLG APSQWGPARA
850 860 870 880 890 900
EEELGVYVYD LMATVVHILD SRTGGSLVAH IKVGETYHQR KEGVTHQQWY LFNDFLIEPI
910 920 930 940 950 960
DKYEAVQFDM NWKVPAILYY VKRNLNSRYN LNIKNPIEAS VLLAEASLAR KQRKTHTTFI
970 980 990 1000 1010 1020
PLMLNEMPQV GDLVGLDAEF VTLNEEEAEL RSDGTKSTIK PSQMSVARIT CVRGQGPNEG
1030 1040 1050 1060 1070 1080
IPFIDDYIST QEQVVDYLTQ YSGIKPGDLD AKISSKHLTT LKSTYLKLRF LIDIGVKFVG
1090 1100 1110 1120 1130 1140
HGLQKDFRVI NLMVPKDQVL DTVYLFHMPR KRMISLRFLA WYFLDLKIQG ETHDSIEDAR
1150 1160 1170 1180 1190
TALQLYRKYL ELSKNGTEPE SFHKVLKGLY EKGRKMDWKV PEPESQTSPK NAAVFSVLAL